Maalox Plus Chewable Tablets 200mg/200mg/25mg Ireland - English - HPRA (Health Products Regulatory Authority)

maalox plus chewable tablets 200mg/200mg/25mg

sanofi-aventis ireland limited t/a sanofi - aluminium oxide, hydrated ph. eur; magnesium hydroxide ph. eur.; dimeticone ph. eur. (as simeticone ph. eur.) - chewable tablet - 200mg/200mg/25 milligram(s) - antacids with antiflatulents; ordinary salt combinations and antiflatulents

Maalox 200mg/175mg per 5ml Oral Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

maalox 200mg/175mg per 5ml oral suspension

opella healthcare france sas t/a sanofi - magnesium hydroxide; aluminium hydroxide - oral suspension - 200mg/175 mg/5ml - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations

Maalox 400mg/400mg Chewable Tablets Ireland - English - HPRA (Health Products Regulatory Authority)

maalox 400mg/400mg chewable tablets

opella healthcare france sas t/a sanofi - magnesium hydroxide; aluminium oxide, hydrated - chewable tablet - 400mg/400 milligram(s) - combinations and complexes of aluminium, calcium and magnesium compounds; ordinary salt combinations

Maalox Plus 200 mg/175 mg/25 mg Oral Suspension Ireland - English - HPRA (Health Products Regulatory Authority)

maalox plus 200 mg/175 mg/25 mg oral suspension

opella healthcare france sas t/a sanofi - aluminium hydroxide; magnesium hydroxide; simeticone - oral suspension - 200 mg/175 mg/25 mg/5ml - antacids with antiflatulents; ordinary salt combinations and antiflatulents

Maalox Plus Chewable Tablets 200mg/200mg/25mg Ireland - English - HPRA (Health Products Regulatory Authority)

maalox plus chewable tablets 200mg/200mg/25mg

opella healthcare france sas t/a sanofi - aluminium oxide, hydrated ph. eur; magnesium hydroxide ph. eur.; dimeticone ph. eur. (as simeticone ph. eur.) - chewable tablet - 200mg/200mg/25 milligram(s) - antacids with antiflatulents; ordinary salt combinations and antiflatulents

Maalox Plus Chewable Tablets 200mg/200mg/25mg Malta - English - Medicines Authority

maalox plus chewable tablets 200mg/200mg/25mg

opella healthcare france sas t/a sanofi 157 avenue charles de gaulle, 92200 neuilly-sur-seine , france - dimeticone, aluminium oxide, hydrated, magnesium hydroxide - chewable tablet - dimeticone 25 mg aluminium oxide, hydrated 200 mg magnesium hydroxide 200 mg - drugs for acid related disorders

Maalox Plus 200mg/175mg/25mg Oral Suspension Malta - English - Medicines Authority

maalox plus 200mg/175mg/25mg oral suspension

opella healthcare france sas t/a sanofi 157 avenue charles de gaulle, 92200 neuilly-sur-seine , france - simethicone, aluminium hydroxide, magnesium hydroxide - oral suspension - magnesium hydroxide 200 mg simethicone 25 mg aluminium hydroxide 175 mg - drugs for acid related disorders

MAALOX PLUS SUSPENSION Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

maalox plus suspension

dksh malaysia sdn bhd - magnesium hydroxide; polymethylsiloxane,activated/simethicone; aluminium hydroxide -

REZOLSTA Israel - English - Ministry of Health

rezolsta

j-c health care ltd - cobicistate; darunavir as ethanolate - film coated tablets - cobicistate 150 mg; darunavir as ethanolate 800 mg - darunavir - rezolsta is indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus (hiv 1) infection in treatment-naïve and treatment-experienced adults with no darunavir resistance-associated substitutions (v11i, v32i, l33f, i47v, i50v, i54l, i54m, t74p, l76v, i84v, l89v).שינוי משטר מינון 2/4/2019pregnancy and postpartumtreatment with rezolsta during pregnancy results in low darunavir exposure (see sections 4.4 and 5.2). therefore, therapy with rezolsta should not be initiated during pregnancy, and women who become pregnant during therapy with rezolsta should be switched to an alternative regimen, see section 4.4 and 4.6. darunavir/ritonavir may be considered as an alternative.